"Osteoporosis" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Reduction of bone mass without alteration in the composition of bone, leading to fractures. Primary osteoporosis can be of two major types: postmenopausal osteoporosis (OSTEOPOROSIS, POSTMENOPAUSAL) and age-related or senile osteoporosis.
| Descriptor ID |
D010024
|
| MeSH Number(s) |
C05.116.198.579 C18.452.104.579
|
| Concept/Terms |
Osteoporosis, Senile- Osteoporosis, Senile
- Osteoporoses, Senile
- Senile Osteoporoses
- Osteoporosis, Involutional
- Senile Osteoporosis
Osteoporosis, Age-Related- Osteoporosis, Age-Related
- Osteoporosis, Age Related
- Bone Loss, Age-Related
- Age-Related Bone Loss
- Age-Related Bone Losses
- Bone Loss, Age Related
- Bone Losses, Age-Related
- Age-Related Osteoporosis
- Age Related Osteoporosis
- Age-Related Osteoporoses
- Osteoporoses, Age-Related
|
Below are MeSH descriptors whose meaning is more general than "Osteoporosis".
Below are MeSH descriptors whose meaning is more specific than "Osteoporosis".
This graph shows the total number of publications written about "Osteoporosis" by people in this website by year, and whether "Osteoporosis" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 1 | 0 | 1 |
| 2001 | 0 | 1 | 1 |
| 2003 | 0 | 1 | 1 |
| 2004 | 2 | 0 | 2 |
| 2005 | 1 | 2 | 3 |
| 2006 | 0 | 1 | 1 |
| 2007 | 0 | 1 | 1 |
| 2008 | 1 | 1 | 2 |
| 2009 | 3 | 0 | 3 |
| 2010 | 2 | 0 | 2 |
| 2012 | 5 | 1 | 6 |
| 2013 | 1 | 2 | 3 |
| 2014 | 2 | 0 | 2 |
| 2015 | 2 | 1 | 3 |
| 2016 | 5 | 1 | 6 |
| 2017 | 48 | 17 | 65 |
| 2018 | 37 | 13 | 50 |
| 2019 | 13 | 7 | 20 |
| 2020 | 4 | 1 | 5 |
| 2021 | 4 | 1 | 5 |
To return to the timeline, click here.
Below are the most recent publications written about "Osteoporosis" by people in Profiles.
-
Challenges and Opportunities for Osteoporosis Care During the COVID-19 Pandemic. J Clin Endocrinol Metab. 2021 11 19; 106(12):e4795-e4808.
-
Adherence to dosing schedule of denosumab therapy for osteoporosis during COVID-19 lockdown: an electronic medical record and pharmacy claims database study from Asia. Osteoporos Int. 2022 Jan; 33(1):251-261.
-
No association of anti-osteoporosis drugs with COVID-19-related outcomes in women: a nationwide cohort study. Osteoporos Int. 2022 Jan; 33(1):273-282.
-
Rethinking of osteoporosis through a sex- and gender-informed approach in the COVID-19 era. Minerva Obstet Gynecol. 2021 Dec; 73(6):754-769.
-
Transthyretin: From Structural Stability to Osteoarticular and Cardiovascular Diseases. Cells. 2021 07 13; 10(7).
-
Blood factors as biomarkers in osteoporosis: points from the COVID-19 era. Trends Endocrinol Metab. 2021 09; 32(9):672-679.
-
Metabolic syndrome in the era of COVID-19 outbreak: impact of lockdown on cardiometabolic health. J Endocrinol Invest. 2021 Dec; 44(12):2845-2847.
-
Diagnosis and Management of Osteoporosis During COVID-19: Systematic Review and Practical Guidance. Calcif Tissue Int. 2021 10; 109(4):351-362.
-
Rev Med Suisse. 2021 04 21; 17(735):763-764.
-
Secondary prevention of fragility fractures: where do we stand during the COVID-19 pandemic? J Endocrinol Invest. 2021 Nov; 44(11):2521-2524.